Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BL MEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   1.3% 1.1% 1.3% 1.2% 5.4% 9.5% 13.6% 11.2%   Credit score (0-100)   82 85 81 82 40 25 15 22   Credit rating   A A A A BBB BB BB BB   Credit limit (kDKK)   65.9 168.1 46.6 155.9 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,468 3,410 3,173 4,036 845 -140 0.0 0.0   EBITDA   1,964 2,460 1,652 2,741 -226 -1,212 0.0 0.0   EBIT   1,782 2,272 1,509 2,580 -323 -1,246 0.0 0.0   Pre-tax profit (PTP)   1,813.4 2,294.5 1,536.0 2,605.9 -303.4 -1,226.8 0.0 0.0   Net earnings   1,406.5 1,788.9 1,192.9 2,032.2 -369.8 -1,036.3 0.0 0.0   Pre-tax profit without non-rec. items   1,813 2,294 1,536 2,606 -303 -1,227 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   251 267 238 150 40.6 7.3 0.0 0.0   Shareholders equity total   2,849 3,138 2,680 3,713 1,843 807 650 650   Interest-bearing liabilities   121 219 114 75.3 78.5 56.3 0.0 0.0   Balance sheet total (assets)   5,307 6,563 5,071 5,809 2,248 1,253 650 650   Net Debt   92.8 219 -98.2 -193 66.8 30.9 -650 -650     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,468 3,410 3,173 4,036 845 -140 0.0 0.0   Gross profit growth   -21.9% -1.7% -6.9% 27.2% -79.1% 0.0% 0.0% 0.0%   Employees   3 2 2 2 2 2 0 0   Employee growth %   50.0% -33.3% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,307 6,563 5,071 5,809 2,248 1,253 650 650   Balance sheet change%   -16.7% 23.7% -22.7% 14.5% -61.3% -44.3% -48.1% 0.0%   Added value   1,782.0 2,272.2 1,508.9 2,580.1 -322.7 -1,245.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,228 -173 -172 -249 -206 -66 -7 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.4% 66.6% 47.6% 63.9% -38.2% 892.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   31.2% 38.8% 26.6% 48.0% -7.3% -70.1% 0.0% 0.0%   ROI %   55.3% 72.8% 50.3% 79.4% -10.3% -88.1% 0.0% 0.0%   ROE %   44.7% 59.8% 41.0% 63.6% -13.3% -78.2% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   53.7% 47.8% 52.9% 65.5% 82.0% 64.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   4.7% 8.9% -5.9% -7.0% -29.6% -2.5% 0.0% 0.0%   Gearing %   4.2% 7.0% 4.3% 2.0% 4.3% 7.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.1% 5.3% 7.1% 7.4% 13.3% 0.3% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   1.8 1.6 1.5 3.3 3.8 1.9 0.0 0.0   Current Ratio   2.0 1.8 2.0 3.7 5.4 2.7 0.0 0.0   Cash and cash equivalent   28.1 0.0 212.2 268.3 11.8 25.4 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,574.3 2,847.9 2,413.6 4,102.8 1,773.0 769.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   594 1,136 754 1,290 -161 -623 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   655 1,230 826 1,371 -113 -606 0 0   EBIT / employee   594 1,136 754 1,290 -161 -623 0 0   Net earnings / employee   469 894 596 1,016 -185 -518 0 0